Cerus Corp. (CERS)
1.825
+0.10
(+5.49%)
USD |
NASDAQ |
Mar 31, 15:25
Cerus EPS Diluted (Quarterly) : -0.0114 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Nephros, Inc. | 0.0055 |
| Abbott Laboratories | 1.030 |
| Accuray, Inc. | -0.1138 |
| Alphatec Holdings, Inc. | -0.1428 |
| Plus Therapeutics, Inc. | -0.0412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.184M |
| Revenue (Quarterly) | 57.75M |
| Total Expenses (Quarterly) | 59.94M |
| Enterprise Value | 347.27M |
| Gross Profit Margin (Quarterly) | 51.51% |
| Profit Margin (Quarterly) | -3.78% |
| Earnings Yield | -4.52% |
| Normalized Earnings Yield | -4.526 |